Polymorphism and
crystal habit play vital roles in dictating the
properties of crystalline materials. Here, the structure and properties
of oxcarbazepine (OXCBZ) form III are reported along with the occurrence
of twisted crystalline aggregates of this metastable polymorph. OXCBZ
III can be produced by crystallization from the vapor phase and by
recrystallization from solution. The crystallization process used
to obtain OXCBZ III is found to affect the pitch, with the most prominent
effect observed from the sublimation-grown OXCBZ III material where
the pitch increases as the length of aggregates increases. Sublimation-grown
OXCBZ III follows an unconventional mechanism of formation with condensed
droplet formation and coalescence preceding nucleation and growth
of aggregates. A crystal structure determination of OXCBZ III from
powder X-ray diffraction methods, assisted by crystal structure prediction
(CSP), reveals that OXCBZ III, similar to carbamazepine form II, contains
void channels in its structure with the channels, aligned along the c crystallographic axis, oriented parallel to the twist
axis of the aggregates. The likely role of structural misalignment
at the lattice or nanoscale is explored by considering the role of
molecular and closely related structural impurities informed by crystal
structure prediction.